135 related articles for article (PubMed ID: 16267275)
21. Chemical validation and optimization of pharmacoperones targeting vasopressin type 2 receptor mutant.
Janovick JA; Spicer TP; Bannister TD; Smith E; Ganapathy V; Scampavia L
Biochem J; 2018 Sep; 475(18):2941-2953. PubMed ID: 30068530
[TBL] [Abstract][Full Text] [Related]
22. An X-linked NDI mutation reveals a requirement for cell surface V2R expression.
Sadeghi HM; Innamorati G; Birnbaumer M
Mol Endocrinol; 1997 Jun; 11(6):706-13. PubMed ID: 9171234
[TBL] [Abstract][Full Text] [Related]
23. Calmodulin interacts with the V2 vasopressin receptor: elimination of binding to the C terminus also eliminates arginine vasopressin-stimulated elevation of intracellular calcium.
Nickols HH; Shah VN; Chazin WJ; Limbird LE
J Biol Chem; 2004 Nov; 279(45):46969-80. PubMed ID: 15319442
[TBL] [Abstract][Full Text] [Related]
24. Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones.
Szalai L; Sziráki A; Erdélyi LS; Kovács KB; Tóth M; Tóth AD; Turu G; Bonnet D; Mouillac B; Hunyady L; Balla A
Front Pharmacol; 2022; 13():811836. PubMed ID: 35153784
[TBL] [Abstract][Full Text] [Related]
25. Polarized expression of the vasopressin V2 receptor in Madin-Darby canine kidney cells.
Andersen-Beckh B; Dehe M; Schülein R; Wiesner B; Rutz C; Liebenhoff U; Rosenthal W; Oksche A
Kidney Int; 1999 Aug; 56(2):517-27. PubMed ID: 10432391
[TBL] [Abstract][Full Text] [Related]
26. Molecular and cellular effects of Tamm-Horsfall protein mutations and their rescue by chemical chaperones.
Ma L; Liu Y; El-Achkar TM; Wu XR
J Biol Chem; 2012 Jan; 287(2):1290-305. PubMed ID: 22117067
[TBL] [Abstract][Full Text] [Related]
27. Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus.
Faerch M; Christensen JH; Rittig S; Johansson JO; Gregersen N; de Zegher F; Corydon TJ
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1518-25. PubMed ID: 19812297
[TBL] [Abstract][Full Text] [Related]
28. Cell surface rescue of kidney anion exchanger 1 mutants by disruption of chaperone interactions.
Patterson ST; Reithmeier RAF
J Biol Chem; 2010 Oct; 285(43):33423-33434. PubMed ID: 20628050
[TBL] [Abstract][Full Text] [Related]
29. Thapsigargin or curcumin does not promote maturation of processing mutants of the ABC transporters, CFTR, and P-glycoprotein.
Loo TW; Bartlett MC; Clarke DM
Biochem Biophys Res Commun; 2004 Dec; 325(2):580-5. PubMed ID: 15530432
[TBL] [Abstract][Full Text] [Related]
30. Vasopressin receptors and pharmacological chaperones: from functional rescue to promising therapeutic strategies.
Mouillac B; Mendre C
Pharmacol Res; 2014 May; 83():74-8. PubMed ID: 24239889
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of cell-surface rerouting of an endoplasmic reticulum-retained mutant of the vasopressin V1b/V3 receptor by a pharmacological chaperone.
Robert J; Auzan C; Ventura MA; Clauser E
J Biol Chem; 2005 Dec; 280(51):42198-206. PubMed ID: 16210325
[TBL] [Abstract][Full Text] [Related]
32. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
Oksche A; Schülein R; Rutz C; Liebenhoff U; Dickson J; Müller H; Birnbaumer M; Rosenthal W
Mol Pharmacol; 1996 Oct; 50(4):820-8. PubMed ID: 8863826
[TBL] [Abstract][Full Text] [Related]
33. Rescue of a pathogenic mutant human glucagon receptor by pharmacological chaperones.
Yu R; Chen CR; Liu X; Kodra JT
J Mol Endocrinol; 2012 Oct; 49(2):69-78. PubMed ID: 22693263
[TBL] [Abstract][Full Text] [Related]
34. A role for ADP-ribosylation factor 6 in the processing of G-protein-coupled receptors.
Madziva MT; Birnbaumer M
J Biol Chem; 2006 Apr; 281(17):12178-86. PubMed ID: 16497672
[TBL] [Abstract][Full Text] [Related]
35. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide.
Schoneberg T; Yun J; Wenkert D; Wess J
EMBO J; 1996 Mar; 15(6):1283-91. PubMed ID: 8635461
[TBL] [Abstract][Full Text] [Related]
36. Functional Rescue of Trafficking-Impaired ABCB4 Mutants by Chemical Chaperones.
Gordo-Gilart R; Andueza S; Hierro L; Jara P; Alvarez L
PLoS One; 2016; 11(2):e0150098. PubMed ID: 26900700
[TBL] [Abstract][Full Text] [Related]
37. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.
Conn PM; Ulloa-Aguirre A; Ito J; Janovick JA
Pharmacol Rev; 2007 Sep; 59(3):225-50. PubMed ID: 17878512
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of pharmacochaperone-mediated rescue of mutant V2 receptor proteins.
Erdem Tuncdemir B; Mergen H; Saglar Ozer E
Eur J Pharmacol; 2019 Dec; 865():172803. PubMed ID: 31738937
[TBL] [Abstract][Full Text] [Related]
39. Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication.
Schöneberg T; Sandig V; Wess J; Gudermann T; Schultz G
J Clin Invest; 1997 Sep; 100(6):1547-56. PubMed ID: 9294123
[TBL] [Abstract][Full Text] [Related]
40. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.
Birnbaumer M; Gilbert S; Rosenthal W
Mol Endocrinol; 1994 Jul; 8(7):886-94. PubMed ID: 7984150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
